Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Chem Res Toxicol
2012 Sep 17;259:1975-84. doi: 10.1021/tx300283t.
Show Gene links
Show Anatomy links
Marine algal toxin azaspiracid is an open-state blocker of hERG potassium channels.
Twiner MJ
,
Doucette GJ
,
Rasky A
,
Huang XP
,
Roth BL
,
Sanguinetti MC
.
???displayArticle.abstract???
Azaspiracids (AZA) are polyether marine dinoflagellate toxins that accumulate in shellfish and represent an emerging human health risk. Although human exposure is primarily manifested by severe and protracted diarrhea, this toxin class has been shown to be highly cytotoxic, a teratogen to developing fish, and a possible carcinogen in mice. Until now, AZA's molecular target has not yet been determined. Using three independent methods (voltage clamp, channel binding assay, and thallium flux assay), we have for the first time demonstrated that AZA1, AZA2, and AZA3 each bind to and block the hERG (human ether-à-go-go related gene) potassium channel heterologously expressed in HEK-293 mammalian cells. Inhibition of K(+) current for each AZA analogue was concentration-dependent (IC(50) value range: 0.64-0.84 μM). The mechanism of hERG channel inhibition by AZA1 was investigated further in Xenopus oocytes where it was shown to be an open-state-dependent blocker and, using mutant channels, to interact with F656 but not with Y652 within the S6 transmembrane domain that forms the channel's central pore. AZA1, AZA2, and AZA3 were each shown to inhibit [(3)H]dofetilide binding to the hERG channel and thallium ion flux through the channel (IC(50) value range: 2.1-6.6 μM). AZA1 did not block the K(+) current of the closely related EAG1 channel. Collectively, these data suggest that the AZAs physically block the K(+) conductance pathway of hERG1 channels by occluding the cytoplasmic mouth of the open pore. Although the concentrations necessary to block hERG channels are relatively high, AZA-induced blockage may prove to contribute to the toxicological properties of the AZAs.
Aasen,
Sub-lethal dosing of azaspiracid-1 in female NMRI mice.
2010, Pubmed
Aasen,
Sub-lethal dosing of azaspiracid-1 in female NMRI mice.
2010,
Pubmed
Alonso,
Design and synthesis of skeletal analogues of gambierol: attenuation of amyloid-β and tau pathology with voltage-gated potassium channel and N-methyl-D-aspartate receptor implications.
2012,
Pubmed
Aune,
Study of possible combined toxic effects of azaspiracid-1 and okadaic acid in mice via the oral route.
2012,
Pubmed
Birinyi-Strachan,
Block of voltage-gated potassium channels by Pacific ciguatoxin-1 contributes to increased neuronal excitability in rat sensory neurons.
2005,
Pubmed
Brüggemann,
Ether-à-go-go encodes a voltage-gated channel permeable to K+ and Ca2+ and modulated by cAMP.
1993,
Pubmed
,
Xenbase
Camm,
Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits.
2012,
Pubmed
Cao,
Involvement of caspase activation in azaspiracid-induced neurotoxicity in neocortical neurons.
2010,
Pubmed
Chen,
Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels.
2002,
Pubmed
,
Xenbase
Cheng,
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
1973,
Pubmed
Colman,
Teratogenic effects of azaspiracid-1 identified by microinjection of Japanese medaka (Oryzias latipes) embryos.
2005,
Pubmed
Duncan,
Erythromycin block of the HERG K+ channel: accessibility to F656 and Y652.
2006,
Pubmed
Fernandez,
Physicochemical features of the HERG channel drug binding site.
2004,
Pubmed
,
Xenbase
Furey,
Azaspiracid poisoning (AZP) toxins in shellfish: toxicological and health considerations.
2010,
Pubmed
Ganetzky,
Neurogenetic analysis of potassium currents in Drosophila: synergistic effects on neuromuscular transmission in double mutants.
1983,
Pubmed
Goldin,
Expression of ion channels by injection of mRNA into Xenopus oocytes.
1991,
Pubmed
,
Xenbase
Huang,
Identification of human Ether-à-go-go related gene modulators by three screening platforms in an academic drug-discovery setting.
2010,
Pubmed
Ito,
Chronic effects in mice caused by oral administration of sublethal doses of azaspiracid, a new marine toxin isolated from mussels.
2002,
Pubmed
Ito,
Multiple organ damage caused by a new toxin azaspiracid, isolated from mussels produced in Ireland.
2000,
Pubmed
James,
Detection of five new hydroxyl analogues of azaspiracids in shellfish using multiple tandem mass spectrometry.
2003,
Pubmed
Jehle,
Novel roles for hERG K(+) channels in cell proliferation and apoptosis.
2011,
Pubmed
Jiménez-Vargas,
Toxin modulators and blockers of hERG K(+) channels.
2012,
Pubmed
Källén,
Is erythromycin therapy teratogenic in humans?
2005,
Pubmed
Kamiya,
Molecular determinants of hERG channel block by terfenadine and cisapride.
2008,
Pubmed
,
Xenbase
Karlsson,
New proposals for testing drugs with IKr-blocking activity to determine their teratogenic potential.
2007,
Pubmed
Kilcoyne,
Improved isolation procedure for azaspiracids from shellfish, structural elucidation of azaspiracid-6, and stability studies.
2012,
Pubmed
Kulagina,
Azaspiracid-1 inhibits bioelectrical activity of spinal cord neuronal networks.
2006,
Pubmed
Lees-Miller,
Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sites.
2000,
Pubmed
,
Xenbase
Luo,
Genomic structure, transcriptional control, and tissue distribution of HERG1 and KCNQ1 genes.
2008,
Pubmed
Mitcheson,
A structural basis for drug-induced long QT syndrome.
2000,
Pubmed
,
Xenbase
Ofuji,
Two analogs of azaspiracid isolated from mussels, Mytilus edulis, involved in human intoxication in Ireland.
1999,
Pubmed
Pardo,
Oncogenic potential of EAG K(+) channels.
1999,
Pubmed
Pardo-Lopez,
Mapping the binding site of a human ether-a-go-go-related gene-specific peptide toxin (ErgTx) to the channel's outer vestibule.
2002,
Pubmed
Redaelli,
Target promiscuity and heterogeneous effects of tarantula venom peptides affecting Na+ and K+ ion channels.
2010,
Pubmed
Rehmann,
Discovery of new analogs of the marine biotoxin azaspiracid in blue mussels (Mytilus edulis) by ultra-performance liquid chromatography/tandem mass spectrometry.
2008,
Pubmed
Román,
Effects of Azaspiracids 2 and 3 on intracellular cAMP, [Ca2+], and pH.
2004,
Pubmed
Román,
Azaspiracid-1, a potent, nonapoptotic new phycotoxin with several cell targets.
2002,
Pubmed
Sanguinetti,
Predicting drug-hERG channel interactions that cause acquired long QT syndrome.
2005,
Pubmed
Sanguinetti,
hERG potassium channels and cardiac arrhythmia.
2006,
Pubmed
Sanguinetti,
A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.
1995,
Pubmed
,
Xenbase
Schreibmayer,
Voltage clamping of Xenopus laevis oocytes utilizing agarose-cushion electrodes.
1994,
Pubmed
,
Xenbase
Stühmer,
Electrophysiological recording from Xenopus oocytes.
1992,
Pubmed
,
Xenbase
Torp-Pedersen,
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
1999,
Pubmed
Twiner,
Cytotoxic and cytoskeletal effects of azaspiracid-1 on mammalian cell lines.
2005,
Pubmed
Twiner,
Comparative effects of the marine algal toxins azaspiracid-1, -2, and -3 on Jurkat T lymphocyte cells.
2012,
Pubmed
Twiner,
Azaspiracid shellfish poisoning: a review on the chemistry, ecology, and toxicology with an emphasis on human health impacts.
2008,
Pubmed
Twiner,
Induction of apoptosis pathways in several cell lines following exposure to the marine algal toxin azaspiracid.
2012,
Pubmed
Twiner,
Transcriptional profiling and inhibition of cholesterol biosynthesis in human T lymphocyte cells by the marine toxin azaspiracid.
2008,
Pubmed
Vale,
Effects of azaspiracid-1, a potent cytotoxic agent, on primary neuronal cultures. A structure-activity relationship study.
2007,
Pubmed
Vilariño,
Azaspiracid substituent at C1 is relevant to in vitro toxicity.
2008,
Pubmed
Vilariño,
Irreversible cytoskeletal disarrangement is independent of caspase activation during in vitro azaspiracid toxicity in human neuroblastoma cells.
2007,
Pubmed
Vilariño,
Cell growth inhibition and actin cytoskeleton disorganization induced by azaspiracid-1 structure-activity studies.
2006,
Pubmed
Vilariño,
Marine toxins and the cytoskeleton: azaspiracids.
2008,
Pubmed
Viluksela,
Cytotoxicity of macrolide antibiotics in a cultured human liver cell line.
1996,
Pubmed
Viluksela,
Comparative liver toxicity of various erythromycin derivatives in animals.
1988,
Pubmed
Waldhauser,
Interaction with the hERG channel and cytotoxicity of amiodarone and amiodarone analogues.
2008,
Pubmed
Warmke,
A family of potassium channel genes related to eag in Drosophila and mammals.
1994,
Pubmed
Warmke,
A distinct potassium channel polypeptide encoded by the Drosophila eag locus.
1991,
Pubmed
Yap,
Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation.
2000,
Pubmed
Zhang,
APETx1 from sea anemone Anthopleura elegantissima is a gating modifier peptide toxin of the human ether-a-go-go- related potassium channel.
2007,
Pubmed